Stock DOVA DOVA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Dova Pharmaceuticals, Inc.

Equities

DOVA

US25985T1025

Delayed Nasdaq
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Dova Pharmaceuticals, Inc. -0.07% +269.92%
2019 Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study - Core and Extension Phase - with Avatrombopag CI
2019 Dova Pharmaceuticals Presents Additional Analyses from the Phase 3 Study Core and Extension Phase CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Dova Pharmaceuticals, Inc. Announces Executive Appointments
CI
Dova Pharmaceuticals, Inc. Announces Management Changes
CI
Dova Pharmaceuticals, Inc. Appoints Nancy J. Wysenski to its Board of Directors
CI
Dova Pharmaceuticals, Inc. Announces Resignation of Mr. Blankenship as Chief Financial Officer
CI
Dova Pharmaceuticals, Inc. Appoints Alex Sapir as New CEO
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DOVA Stock
  4. News Dova Pharmaceuticals, Inc.
  5. Insiders